S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
NASDAQ:REVB

Revelation Biosciences (REVB) Stock Price, News & Analysis

$0.50
-0.03 (-5.65%)
(As of 12/29/2023 ET)
Today's Range
$0.49
$0.51
50-Day Range
$0.49
$0.76
52-Week Range
$0.47
$11.39
Volume
99,575 shs
Average Volume
100,237 shs
Market Capitalization
$3.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00

Revelation Biosciences MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
2,895.8% Upside
$15.00 Price Target
Short Interest
Bearish
6.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.44mentions of Revelation Biosciences in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$21,673 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($1.29) to ($1.54) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars


REVB stock logo

About Revelation Biosciences Stock (NASDAQ:REVB)

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-100, a potential therapy for the prevention and treatment of healthcare-associated bacterial infection resulting from surgery, severe burns, urinary tract infection, sepsis, and antibiotic resistance; REVTx-200, a potential intranasal therapy; and REVTx-300, a potential therapy for the treatment of chronic organ disease, including chronic kidney disease. It is also developing REVTx-99b, a treatment for food allergies; REVTx-99a, an anti-viral nasal drop solution for the potential prevention or treatment of respiratory viral infection; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, influenza A, influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.

REVB Stock Price History

REVB Stock News Headlines

Revelation Biosciences Inc Ordinary Shares REVB
REVB Releases Earnings and Prepares for Trials
New Year's Sale: Get MarketBeat All Access Free For 30 Days
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription
Revelation Biosciences GAAP EPS of -$0.42
Claim Your $300 MarketBeat Account Credit
Click the link below to claim your $300.00 account credit toward MarketBeat All Access. Pay just $99.00 for your 2024 MarketBeat All Access subscription (normally $399.00)
REVB Reports Solid Balance Sheet and Remains on Track
REVB: REVB Looks Attractive Ahead of Trials
REVB - Revelation Biosciences, Inc.
Revelation Biosciences GAAP EPS of $1.96
REVB Revelation Biosciences, Inc.
The Prophet Muhammad’s revelation
See More Headlines
Receive REVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/31/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
4/04/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:REVB
Fax
N/A
Employees
6
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.00
High Stock Price Target
$15.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+2,895.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-10,830,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.54 per share

Miscellaneous

Free Float
6,121,000
Market Cap
$3.15 million
Optionable
Not Optionable
Beta
0.48
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report














REVB Stock Analysis - Frequently Asked Questions

Should I buy or sell Revelation Biosciences stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Revelation Biosciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" REVB shares.
View REVB analyst ratings
or view top-rated stocks.

What is Revelation Biosciences' stock price target for 2024?

1 Wall Street analysts have issued 1 year target prices for Revelation Biosciences' stock. Their REVB share price targets range from $15.00 to $15.00. On average, they anticipate the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 2,895.8% from the stock's current price.
View analysts price targets for REVB
or view top-rated stocks among Wall Street analysts.

How have REVB shares performed in 2023?

Revelation Biosciences' stock was trading at $6.6535 on January 1st, 2023. Since then, REVB shares have decreased by 92.5% and is now trading at $0.5007.
View the best growth stocks for 2023 here
.

When is Revelation Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024.
View our REVB earnings forecast
.

How were Revelation Biosciences' earnings last quarter?

Revelation Biosciences, Inc. (NASDAQ:REVB) issued its quarterly earnings results on Thursday, November, 9th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.11.

When did Revelation Biosciences' stock split?

Revelation Biosciences's stock reverse split on the morning of Monday, January 30th 2023. The 1-35 reverse split was announced on Monday, January 30th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 30th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Revelation Biosciences?

Shares of REVB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:REVB) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -